Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sphere of biopharmaceuticals, offering promising developments across several health care and industrial apps. With its structural similarity to Normally derived human serum albumin, OsrHSA provides a safer, far more dependable substitute for therapeutic use, par